Sardomozide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSardomozide
Drug Alias Name沙多齐特CGP-48664ACGP-48664SAM-486ASAM-486
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS-adenosylmethionine decarboxylase 1 inhibitors
TargetsS-adenosylmethionine decarboxylase 1
Therapy Area/IndicationsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A